HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazue Watanabe Selected Research

HLA-B55 antigen

4/2019Identification of novel human leukocyte antigen-A*11:01-restricted cytotoxic T-lymphocyte epitopes derived from osteosarcoma antigen papillomavirus binding factor.
8/2014Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazue Watanabe Research Topics

Disease

10Neoplasms (Cancer)
10/2020 - 10/2008
4Osteosarcoma (Osteogenic Sarcoma)
10/2020 - 08/2014
2Sarcoma (Soft Tissue Sarcoma)
10/2020 - 02/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
08/2019 - 10/2018
2Testicular Neoplasms (Testicular Cancer)
01/2017 - 01/2017
2Colonic Neoplasms (Colon Cancer)
01/2017 - 01/2017
2Lung Neoplasms (Lung Cancer)
01/2017 - 01/2017
1Renal Cell Carcinoma (Grawitz Tumor)
10/2020
1Necrosis
02/2020
1Adenocarcinoma
08/2019
1Nausea
10/2018
1Headache (Headaches)
10/2018
1Fatigue
10/2018
1Neoplasm Metastasis (Metastasis)
01/2017
1Carcinoma (Carcinomatosis)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017
1Microsatellite Instability
01/2017
1Lymphoma (Lymphomas)
02/2013
1Infections
10/2008

Drug/Important Bio-Agent (IBA)

10Peptides (Polypeptides)IBA
10/2020 - 08/2014
9AntigensIBA
10/2020 - 10/2008
4SurvivinIBA
02/2020 - 01/2017
3HLA-A24 AntigenIBA
10/2020 - 01/2017
3HLA Antigens (Human Leukocyte Antigens)IBA
04/2019 - 01/2017
2Single-Chain AntibodiesIBA
10/2020 - 08/2014
2Protein Subunit VaccinesIBA
08/2019 - 10/2018
2GemcitabineFDA Link
08/2019 - 10/2018
2HLA-B55 antigenIBA
04/2019 - 08/2014
2EpitopesIBA
04/2019 - 08/2014
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2020
1Interferon-alpha (Interferon Alfa)IBA
02/2020
1incomplete Freund's adjuvantIBA
02/2020
1LigandsIBA
08/2019
1Immune Checkpoint InhibitorsIBA
08/2019
1tegafur-gimeracil-oteracilIBA
08/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2019
1UracilIBA
10/2018
1TegafurIBA
10/2018
1Messenger RNA (mRNA)IBA
01/2017
1Histocompatibility Antigens Class IIBA
01/2017
1tapasinIBA
01/2017
1HLA-A2 Antigen (HLA A2 Antigen)IBA
08/2014
1Monoclonal AntibodiesIBA
08/2014
1HLA-A Antigens (HLA-A)IBA
08/2014
1Cancer VaccinesIBA
02/2013
1HLA-A*24:02 antigenIBA
02/2013

Therapy/Procedure

6Immunotherapy
02/2020 - 02/2013
5Therapeutics
02/2020 - 02/2013